Cardiovid Plus, Cardiovascular Active Dietary Supplement, 60 Softgels
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3356-2017.
Failure to meet with 21 CFR Part 111, CGMPs, assuring identity, purity, and composition of dietary supplements.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3356-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Duy Drugs Inc. or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-3356-2017.
Duy Drugs Inc.
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Duy Drugs Inc. Recall FAQ
Duy Drugs Inc. is the subject of a supplements safety report: Cardiovid Plus, Cardiovascular Active Dietary Supplement, 60 Softgels. The notice was published on July 21, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 411 units are potentially affected.